In this episode of the podcast, Kyle sits down for the 2nd edition of Vital Psychedelic Conversations; this week with Annie & Michael Mithoefer, who are best known for groundbreaking trials they’ve been involved in, including two MAPS-sponsored Phase II trials studying MDMA-assisted therapy for PTSD, a study providing MDMA-assisted sessions to therapists completing the MAPS therapist training, and a pilot study treating couples with MDMA-assisted therapy combined with Cognitive Behavioral Conjoint Therapy. They discuss why they connected so much with breathwork; what trusting the process means (for the patient and facilitator); the concept of inner healing capacity; how the communal, group process aspect of breathwork is inspiring ideas for group MDMA sessions; updates on new trials for 2022; their best advice and biggest takeaways they’ve learned from decades in the field, and more!

The post PT288 – Annie & Michael Mithoefer – Vital Psychedelic Conversations appeared first on Psychedelics Today.

Previous articleNuminus Identified as a Licensed Psilocybin Supplier by Health Canada
Next articleRed Light Holland’s Partner CCrest Laboratories Approved By Health Canada to Supply Psilocybin to the Special Access Program